Seminars in Pediatric Neurology
Volume 17, Issue 1 , Pages 54-57, March 2010

Dramatic First Words Spoken in 2 Children After Vagus Nerve Stimulation

  • Marie F. Grill, MD

      Affiliations

    • Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ
  • ,
  • Yu-tze Ng, MD, FRACP

      Affiliations

    • Division of Pediatric Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ
    • Corresponding Author InformationAddress reprint requests to Yu-tze Ng, Division of Pediatric Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, 500 West Thomas Road 400, Phoenix, AZ 85013

Vagus nerve stimulation has become an accepted adjunctive treatment for refractory epilepsy with more recent FDA approval in the treatment of depression. Many “positive” effects have been noted in patients with epilepsy namely increased alertness, improved cognition, behavior and mood. These changes appear to be independent of seizure reduction and antiepileptic drug decrease. We present two children (aged 8 and 9 years) who were non-verbal and spoke their first words shortly after vagus nerve stimulators were implanted. The mechanism is unclear although vagus nerve stimulation has been clearly shown to induce neuronal, chemical and perfusion changes in both subcortical and cortical regions of the brain. There is likely a combined effect on primary speech areas as well subcortical and mamillothalamic tracts, and possibly even stimulation and changes at the local vocal cord level contributing to this phenomenon. Our observation has important implications in encephalopathic patients both with and without epilepsy.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Ng is on the Medical Advisory Board for Lundbeck Pharmaceuticals and the speakers' bureau for UCB Pharma and Cyberonics Inc.

PII: S1071-9091(10)00016-1

doi:10.1016/j.spen.2010.02.009

Seminars in Pediatric Neurology
Volume 17, Issue 1 , Pages 54-57, March 2010